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ABSTRACT:  
The present research has been undertaken with the aim to develop a topical gel formulation of Diclofenac sodium using 
different gelling agent carbopol, Na CMC, HPMC (K4M) and sodium alginate in different concentration, which would 
attenuate the gastrointestinal relater toxicities associated with oral administration. They were evaluated for physicochemical 
properties such as homogeneity, grittiness, viscosity, pH, Spreadability, drug content, skin irritancy, in vitro drug release, 
stability studies. The in vitro drug release rate of gel was evaluated using Franz diffusion cell containing cellophane 
membrane with phosphate buffer pH 6.8 as the receptor medium. Studies showed that drug release was decrease with 
increase in gelling agent concentration because polymer concentration increases, viscosity increases. Drug was absorbed 
from site of application as long as it remains in higher concentration gelling agent in solution form. 
Keywords: Diclofenac Sodium, carbopol, hydroxyl propyl methyl cellulose, sodium alginate anti‐inflammatory activity. 
 
INTRODUCTION 
Diclofenac Sodium is a potent member of the nonsteroidal anti-inflammatory drugs (NSAIDs), widely used because of its 
strong analgesic, antipyretic and anti-inflammatory effects (1-2).  
Oral dose of diclofenac potassium causes an increased risk of serious gastrointestinal adverse events including 
bleeding, ulceration and perforation of the stomach or the intestines which could be fatal. Due to the presence of these oral 
adverse effects necessitate the need for investigating other route of drug delivery of diclofenac potassium. Transdermal 
delivery of the drug can improve its bioactivity with reduction of the side effects and enhance the therapeutic efficacy (3-4). 
Delivery of drugs to the skin is an effective and targeted therapy for local dermatological disorders. This route of 
drug delivery has gained popularity because it avoids first pass effects, gastrointestinal irritation, and metabolic degradation 
associated with oral administration (5-6). Topical gel formulations provide a suitable delivery system for drugs because they 
are thixotropic, greaseless, easily spreadable, easily removable, emollient, nonstaing, compatible with several excipients and 
water-soluble or miscible. Percutaneous absorption of drugs from topical formulations involves the release of the drug from 
the formulation and permeation through skin to reach the target tissue. The release of the drug from topical preparations 
depends on the physicochemical properties of the vehicle and the drug employed. (7-9) 
Skin is one of the most readily accessible organs of human body for topical administration and main route of 
topical drug delivery system. Numbers of medicated products are applied to the skin or mucous membrane that either 
enhance or restore a fundamental function of a skin or pharmacologically alter an action in the underlined tissues. (10) 
Topical drugs used to control pain act locally on damaged or dysfunctional soft tissues or peripheral nerves, and their actions 
may be on the inflammatory response itself or on sensory neurons (11). 
An improved Diclofenac formulation with a high degree of skin permeation could be useful in the treatment of not only 
locally inflamed skin tissues, but also inflammatory and painful states of supporting structures of the body bones, ligaments, 
joints, tendons and muscles. (12) 
                The objective of present study was conducted to develop a topical gel formulation of diclofenac sodium using four 
types of gelling agents: carbopol 934, hydroxypropylmethylcellulose (HPMC), carboxymethylcellulose sodium (Na CMC) 
and sodium alginate for enhancing the skin penetration. Effect of penetration enhancer (propylene glycol) on the release has 
been studied. The gels were evaluated for physical appearance, rheological behaviour, drug release and stability. The drug 
release from all gelling agents through a standard cellophane membrane was evaluated using Franz diffusion cell. 
MATERIALS 
Diclofenac Sodium (Gift sample, DD Pharma Jaipur) carbopol-934, Na CMC salt medium viscosity 200-400 cPs, HPMC 
(K4M), sodium alginate, propylene glycol, triethanolamine, propylparaben, sodium hydroxide, potassium di hydrogen ortho 
phosphate, ethanol used were analytical grade. 
METHODS 
Preparation of gels: 
Carbopol 934 gels were formulated by ﬁrst preparing a stock solution of the Carbopol in distilled water and propylene 
glycol. Separately Diclofenac sodium (1%w/w) was dissolved in preweighted amounts of propylene glycol and ethanol. 
Solvent blend was transferred to carbopol container and agitated for additional 20 min. The dispersion was then allowed to 
hydrate and swell for 60 min, finally adjusted neutral pH by sodium hydroxide solution with stirring.  All the samples were 
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allowed to equilibrate for at least 24 hours at room temperature prior to performing rheological measurements (13-14).(Table 
1) 
Other gel formulations were prepared by dispersing HPMC, Na CMC and sodium alginate in water by continuous 
stirring. Diclofenac sodium was dissolved in propylene glycol or ethanol and the solution was added gently to HPMC, Na 
CMC and sodium alginate dispersion under continuous stirring. The mixture was stirred gently with a spatula until 
homogeneous gel was formed. All the samples were allowed to equilibrate for at least 24 h at room temperature prior to 
performing rheological measurements. 
Characterization of Formulations 
The prepared diclofenac sodium gels were inspected visually for their homogeneity, grittiness, viscosity, Spreadability, pH, 
drug content, skin irritancy, in vitro drug release, stability studies.  
Homogeneity 
All developed gels were tested for homogeneity by visual inspection after the gels have been set in the container. They were 
tested for their appearance and presence of any aggregates. (15) 
 
 
Grittiness 
All the formulations were evaluated microscopically for the presence of particles if any no appreciable particulate matter was 
seen under light microscope. Hence obviously the gel preparation fulfils the requirement of freedom from particular matter 
and from grittiness as desired for any topical preparation. (15) 
Viscosity 
The measurement of viscosity of the prepared gel was done with a Brookfield viscometer. The gels were rotated at 20 and 30 
rpm using spindle no. 64. At each speed, the corresponding dial reading was noted. (15)  
Spreadability 
Spreadability is expressed in terms of time in seconds taken by two slides to slip off from gel and placed in between the 
slides under the direction of certain load, lesser the time taken for separation of two slides, better the spreadability. (15) 
It is calculated by using the formula: S = M. L / T 
Where M = weight tied to upper slide 
L = length of glass slides 
T = time taken to separate the slides 
 
pH 
The pH was measured in each gel, using a pH meter, which was calibrated before each use with standard buffer solutions at 
pH 4, 7, 9. The electrode was inserted in to the sample 10 min priors to taking the reading at room temperature. (16) 
Drug content  
To ensure uniform formulation of the gel, it was sampled from the different locations in the mixer and assayed for the drug 
content. Drug content of the gels was determined by dissolving an accurately weighed quantity of gel (about 1 gm) in about 
100 ml of pH 6.8 phosphate buffer. (17) These solutions were quantitatively transferred to volumetric flasks and appropriate 
dilutions were made with the same buffer solution. The resulting solutions were then filtered 0.45 mm membrane filters 
before subjecting the solution to spectrophotometric analysis for diclofenac sodium at 276 nm. Drug content was determined 
from the standard curve of diclofenac sodium. 
Skin irritation  
The albino mice of either sex weighing 20‐22gms were used for this test. The intact skin was used. The hair was removed 
from the mice 3 days before the experiment. The animals were divided into two batches and each batch was again divided 
into two groups. The gel containing drug was used on test animal. A piece of cotton wool soaked in saturated drug solution 
was placed on the back of albino mice taken as control. The animals were treated daily up to seven days and finally the 
treated skin was examined visually for erythema and edema. 
In Vitro Release 
The in vitro release experiments were carried out by using Franz-diffusion cells apparatus from different formulations. 
An exact amount of formulations (1.0 g) was spread out on membrane positioned between the donor and receptor chambers 
with an available diffusion area. The receptor compartment was filled with phosphate buffer pH 6.8 and continuously stirred 
with a small magnetic bar at a speed of 50 rpm during the experiments to ensure homogeneity and maintained at 37.2±0.5 
0C. The samples were withdrawn at various time intervals and replaced with the same volume of PBS. Sink conditions were 
met in all cases. The samples were analyzed spectrophotometrically at 276 nm (Shimadzu UV-Visible-1800). 
Stability study 
For the evaluation of stability study, maintaining the formulations at an ambient condition over a period of two months. The 
physical appearance, pH value, drug content, rheological properties, drug release studies were determined periodically after 
the 1st and 2nd month after topical gel preparations. 
RESULTS AND DISCUSSION 
Characterization of Formulations 
The prepared formulations shared a smooth and homogeneous appearance. The Carbopol diclofenac sodium gels were 
transparent while HPMC and Na CMC gels were white viscous and sodium alginate gels were brownish gummy with 
smooth and homogeneous appearance. 
All preparations were easily spreadable, with acceptable bioadhesion and fair mechanical properties. The pH values ranged 
from 5.71±0.18 to 6.82±0.27, which are considered acceptable to avoid the risk of irritation after skin application (18). 
Viscosity is an important physical property of topical formulations, which affects the rate of drug release; in general, an 
increase of the viscosity vehicles would cause a more rigid structure with a consequent decrease of the rate of drug release 
(19). 
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Viscosity increased (from 2930.42±0.82 cPs to 4208.35±1.31 cPs, Table 2) as polymer concentration increased. Increased 
consistency was ascribed to enhanced polymeric entanglements, thereby increasing the resistance to deformation. (20) 
For all formulations the viscosity was found to be lower from 2.3 to 4.1 times as the rotational speed increased. In 
fact, when the speed increases, the normally disarranged molecules of the vehicle are caused to align their long axes in the 
direction of flow. Such orientation reduces the internal resistance of the material and hence decreases the viscosity. 
The results of skin irritancy studies are shown that the prepared gels do not produce any skin irritation and are well tolerated 
by mice. 
The result of stability studies are shown that there were no significant changes in the viscosity, drug content and physical 
appearance of the gel, after storing at different temperature conditions for three months. These results indicate that drug 
remain stable after stability studies. 
In Vitro Release Results 
In vitro dissolution profile of diclofenac sodium gels containing different concentration of carbopol, HPMC, Na CMC and 
sodium alginate are shown in table 3 and fig. 1-4. 
Release profiles of diclofenac sodium from various gel formulations across the cellulose membrane deplicated that drug 
release decrease with increase in concentration of the gelling agent. The drug release values were also found lower for the 
formulation in which polymer concentration was kept high (Table 3). In addition, viscosity increased (from 2967±0.23 cPs 
to 4687±0.31 cPs, Table2) as polymer concentration increased. Viscosity is negatively related to the release of active 
substance from formulations and its penetration through the diffusion barriers. The decrease in the release could be attributed 
to increased microviscosity of the gel by increasing polymer concentration. Thus, both high concentration of polymer and 
high viscosity compete each other in decreasing the release of active substance from the formulation. In our study, the 
finding that higher polymer concentration resulted in lower drug release from the vehicles is in agreement with Lauffer’s 
molecular diffusion theory of polymer gels, which states that the diffusion coefficient of a solute is inversely proportional to 
the volume fraction occupied by the gel-forming agent. (21-23) 
 
Table 1: Different gel formulations 
 
Table 2: Physicochemical characteristics of diclofenac sodium gels formulations 
 
Formulation Homogeneity  Grittiness Spreadability pH Viscosity Drug 
content 
F1 ++ - 31.87±1.50 6.56±0.19 3245.31±1.11 98.54±0.13 
F2 +++ - 21.34±1.21 6.82±0.28 3789.28±1.01 97.78±0.12 
F3 +++ - 17.61±1.11 6.73±0.21 4208.35±1.31 99.57±0.14 
F4 ++ - 33.21±1.23 6.66±0.17 2908.42±0.82 97.34±0.18 
F5 +++ - 19.08±1.17 6.71±0.19 3476.32±1.10 98.61±0.22 
F6 +++ - 12.61±1.09 5.71±0.18 3965.87±1.21 98.72±0.09 
F7 +++ - 27.78±1.18 6.75±0.21 3121.33±1.73 96.84±0.17 
F8 +++ - 14.31±1.42 6.66±0.17 3655.67±1.47 98.39±0.14 
F9 +++ - 11.13±1.18 6.56±0.17 4167.25±1.31 99.54±0.16 
F10 ++ - 24.61±1.28 6.45±0.16 3217.43±1.28 101.21±0.11 
F11 +++ - 17.11±1.08 6.66±0.16 3687.33±1.42 98.31±0.17 
F12 ++ - 11.61±1.27 6.43±0.15 4165.41±1.32 99.25±0.19 
S.N Ingredients 
(%w/w) 
Formulation 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 
1 Diclofenac 
sodium 
1 1 1 1 1 1 1 1 1 1 1 1 
2 Carbopol-934  1 1.5 2 - - - - - - - - - 
3 Na CMC - - - 1 1.5 2 - - - - - - 
4 HPMC - - - - - - 1 1.5 2 - - - 
5 Sodium alginate - - - - - - - - - 1 1.5 2 
6 Propylene 
glycol 
 
15 15 15 15 15 15 15 15 15 15 15 15 
7 Triethanolamine 
 
0.4 0.5 0.6 0.4 0.5 0.6 0.4 0.5 0.6 0.4 0.5 0.6 
8 Ethanol 30 30 30 30 30 30 30 30 30 30 30 30 
9 Propyl paraben 
 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
10 Water up to 100 100 100 100 100 100 100 100 100 100 100 100 
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 N=3 
                                                            Excellent +++, Good ++, Satisfactory +, No grittiness ‐ 
Table 3: Cumulative % Drug release from gel formulations at different time intervals 
Formulation Cumulative % 
Released in 60 
min 
Cumulative % 
Released in 120 
min 
Cumulative % 
Released in 360 
min 
F1 10.45 ± 0.09 33.18 ± 0.23 81.21 ± 1.12 
F2 8.67 ± 0.08 28.45 ± 0.48 78.19 ± 0.89 
F3 6.87 ± 0.09 21.05 ± 0.32 72.35 ± 0.68 
F4 14.05 ± 1.01 35.87 ± 1.19 87.90 ± 1.11 
F5 11.15 ± 0.69 30.64 ± 0.99 81.45 ± 1.09 
F6 9.65 ± 0.71 26.77 ± 0.89 77.32 ± 0.88 
F7 13.11 ± 0.76 34.35 ± 0.30 88.55± 0.83 
F8 11.05 ± 1.03 29.90 ± 1.09 82.13 ± 1.34 
F9 8.98 ± 0.90 26.16 ± 0.78 77.11 ± 1.11 
F10 10.15 ± 0.67 33.01 ± o.12 80.23 ± 1.37 
F11 8.55 ± 0.89 28.45 ± 0.62 78.09 ±1.41 
F12 6.05 ± 0.72 21.76 ± 0.57 71.67 ± 1.25 
N= 
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Figure 1: Cumulative %Drug release from carbopol 934 gel formulations at different time intervals 
 
 
Figure 2: Cumulative %Drug release from Na CMC gel formulations at different time intervals 
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Figure 3: Cumulative %Drug release from HPMC gel formulations at different time intervals 
 
 
 
Figure 4: Cumulative %Drug release from Sodium Alginate gel formulations at different time intervals 
 
 
CONCLUSION 
Diclofenac sodium is a non-steroidal anti‐inflammatory drug (NSAID) that exhibits anti‐inflammatory, analgesic, and 
antipyretic activities. To overcome the side effects associated with oral diclofenac sodium therapy and to have the benefits 
associated with topical therapy; diclofenac sodium topical gels are prepared in this study. 
Studies showed that drug release was decrease with increase in gelling agent concentration because polymer concentration 
increases, viscosity increases. Drug was absorbed from site of application as long as it remains in higher concentration 
gelling agent in solution form. So with an intention to keep the diclofenac sodium in solution form, and thus prolonging the 
time of absorption, gel formulations were prepared. 
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